Clinical Trial Update: Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation [Phase 2]

View source ↗

Summary

A Phase 2 bronchoscopic lung volume reduction trial for pulmonary emphysema in the Netherlands sponsored by Aeris Therapeutics has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Emphysema

Drugs mentioned

• Aeris BLVR Initial Formulation

Snippet

Sponsor: Aeris Therapeutics | Conditions: Pulmonary Emphysema | Phase 2 | Status: TERMINATED